The Role of 1-(Piperidin-4-yl)-1,3-dihydrobenzoimidazol-2-one in CNS Drug Discovery
The relentless pursuit of effective treatments for central nervous system (CNS) disorders is a cornerstone of modern pharmaceutical research. This complex field often relies on the innovative use of specialized chemical building blocks. One such compound that has proven invaluable in this arena is 1-(Piperidin-4-yl)-1,3-dihydrobenzoimidazol-2-one, identified by its CAS number 20662-53-7. As a dedicated manufacturer and supplier, NINGBO INNO PHARMCHEM CO.,LTD. is at the forefront of providing this crucial intermediate to the scientific community.
1-(Piperidin-4-yl)-1,3-dihydrobenzoimidazol-2-one is a sophisticated heterocyclic organic molecule characterized by its off-white to slightly yellow powder appearance and high purity, typically 99%. Its molecular architecture, featuring a fused benzimidazole ring system attached to a piperidine moiety, endows it with unique chemical properties that are highly advantageous for drug design targeting CNS receptors. This makes it a prime candidate for researchers looking to buy intermediates for CNS-active compounds.
The significance of this compound in CNS drug discovery stems from its potential to be incorporated into molecules that modulate key neurotransmitter systems. Specifically, it serves as a foundational structure for the synthesis of potential dopamine receptor modulators and serotonin antagonists. These classes of drugs are vital for treating a spectrum of neurological and psychiatric conditions, including schizophrenia, depression, anxiety disorders, and movement disorders like Parkinson's disease. By providing a reliable source for this intermediate, NINGBO INNO PHARMCHEM CO.,LTD. empowers scientists to explore new therapeutic avenues.
For procurement managers and R&D scientists, sourcing CAS 20662-53-7 requires confidence in both the quality and the supply chain. As a leading manufacturer in China, we offer competitive pricing and consistent product availability, ensuring that your research and development projects are not stalled by supply limitations. We encourage interested parties to contact us for a quote, to explore bulk purchase options, and to understand the tangible benefits of partnering with a specialized chemical supplier. Our commitment is to facilitate the advancement of CNS therapeutics through the provision of high-quality chemical intermediates.
The intricate challenges of CNS drug discovery demand precise and reliable chemical tools. 1-(Piperidin-4-yl)-1,3-dihydrobenzoimidazol-2-one is one such tool, and NINGBO INNO PHARMCHEM CO.,LTD. is your trusted source. We are dedicated to supporting your efforts to develop the next generation of therapies for neurological disorders, and we stand ready to fulfill your requirements for this essential pharmaceutical intermediate.
Perspectives & Insights
Core Pioneer 24
“We are dedicated to supporting your efforts to develop the next generation of therapies for neurological disorders, and we stand ready to fulfill your requirements for this essential pharmaceutical intermediate.”
Silicon Explorer X
“The relentless pursuit of effective treatments for central nervous system (CNS) disorders is a cornerstone of modern pharmaceutical research.”
Quantum Catalyst AI
“This complex field often relies on the innovative use of specialized chemical building blocks.”